1. Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma
   Xiuchao Geng et al, 2022, Cell Death & Disease CrossRef
2. Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance
   Liliana Montella et al, 2023, International Journal of Cancer CrossRef
3. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
   Peter Wai Tik Lee et al, 2024, Cancers CrossRef
4. The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
   Alireza Mafi et al, 2024, Non-coding RNA Research CrossRef
5. Protein structuromics: A new method for protein structure–function crosstalk in glioma
   Nan Xiao et al, 2024, Proteins: Structure, Function, and Bioinformatics CrossRef
6. The pathogenesis mechanism and potential clinical value of lncRNA in gliomas
   Yuan Liu et al, 2024, Discover Oncology CrossRef
7. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
   Bianca Oana Pirlog et al, 2023, Expert Reviews in Molecular Medicine CrossRef
8. Circulating tumor RNA and exosomes as disease prognosis and therapy effectivity novel markers in case of malignant gliomas in adults
   Elizaveta V. Ermolaeva et al, 2024, Pediatrician (St. Petersburg) CrossRef
9. GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin
   Haiyang Wang et al, 2022, Cancer Gene Therapy CrossRef
10. The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
    Xi‐Xi Li et al, 2024, The Kaohsiung Journal of Medical Sciences CrossRef
11. Development of Hollow Gold Nanoparticles for Photothermal Therapy and Their Cytotoxic Effect on a Glioma Cell Line When Combined with Copper Diethyldithiocarbamate
    Jin Liu et al, 2024, Biological and Pharmaceutical Bulletin CrossRef
12. CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling
    Yang Jiang et al, 2022, Cell Death & Disease CrossRef
13. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
    Yang Jiang et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
14. Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways
    Hashem O. Alsaab et al, 2024, Pathology - Research and Practice CrossRef
15. Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription
    Zongyang Li et al, 2024, Phytomedicine CrossRef